Boc-L-Alanine

Boc-L-Alanine
Product Description

Flamma Spa offers a wide range of intermediates which includes boc-L-alanine. Alternative compound name: boc-L-ala-OH; boc-beta-alanine. This is part of our boc-intermediates category. Contact us for more information.

Flamma

  • Country/Region:
    Italy
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
Manufacturer/Innovator

Flamma

  • Country/Region:
    Italy
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
Manufacturer/Innovator

More Products from Flamma (99)

  • Acetyl-L-Carnitine HCL

    Product Acetyl-L-Carnitine HCL

    Flamma Spa offers a wide range of active pharmaceutical ingredients which includes acetyl-l-carnitine HCL. Contact us for more information.
  • Acetyl-L-Glutamine

    Product Acetyl-L-Glutamine

    Flamma Spa offers a wide range of active pharmaceutical ingredients which includes acetyl-l-glutamine. Contact us for more information.
  • Acexamic Acid

    Product Acexamic Acid

    Flamma Spa offers a wide range of active ingredients which includes acexamic acid. Contact us for more information.
  • Aminexil

    Product Aminexil

    Flamma Spa offers a wide range of active ingredients which includes aminexil. Contact us for more information.
  • Boc-cis-4-Methoxy-D-proline

    Product Boc-cis-4-Methoxy-D-proline

    Flamma Spa offers a wide range of intermediates which includes boc-cis-4-methoxy-d-proline. Alternative compound name: cis-boc-4-methoxy-d-proline. It belongs to boc-intermediates category. Contact us for more information.
  • Boc-Glycine

    Product Boc-Glycine

    Flamma Spa offers a wide range of intermediates which includes boc-glycine. Alternative compound name: boc-gly-OH; boc-aminoxyacetic acid. It belongs to boc-intermediates category. Contact us for more information.
  • Boc-L-Asparagine

    Product Boc-L-Asparagine

    Flamma Spa offers a wide range of intermediates which includes boc-l-asparagine. Alternative compound name: boc-asn-OH. It belongs to boc-intermediates category. Contact us for more information.
  • Boc-L-bis(4-fluorophenyl)alanine

    Product Boc-L-bis(4-fluorophenyl)alanine

    Flamma Spa offers a wide range of intermediates which includes boc-l-bis(4-fluorophenyl)alanine. Alternative compound name: n-{[(1,1-dimethylethyl)oxy]carbonyl}-4-fluoro-beta-(4-fluorophenyl)-l-phenylalanine. It belongs to boc-intermediates category. Contact us for more information.
  • Boc-L-Glutamic acid 5-benzylester

    Product Boc-L-Glutamic acid 5-benzylester

    Flamma Spa offers a wide range of intermediates which includes boc-l-glutamic acid 5-benzylester. Alternative compound name: boc-glu(obzl)-OH; 5-benzyl n-boc-l-glutamate. It belongs to boc-intermediates category. Contact us for more information.
  • Boc-L-Methionin

    Product Boc-L-Methionin

    Flamma Spa offers a wide range of intermediates which includes boc-l-methionin. Alternative compound name: boc-met-OH; boc-met. It belongs to boc-intermediates category. Contact us for more information.
  • Boc-L-Proline

    Product Boc-L-Proline

    Flamma Spa offers a wide range of intermediates which includes boc-l-proline. Alternative compound name: boc-pro-OH. It belongs to boc-intermediates category. Contact us for more information.
  • Boc-L-Prolinol

    Product Boc-L-Prolinol

    Flamma Spa offers a wide range of intermediates which includes boc-l-prolinol. Alternative compound name: (s)-(-)-1-boc-2-pyrrolidinemethanol. It belongs to boc-intermediates category. Contact us for more information.

Flamma resources (12)

  • News The Flamma Group Expands Globally Reinforcing Its Commitment to Growth

    The Flamma Group  (“Flamma”) is a preeminent Contract Development and Manufacturing Organization (CDMO) of New Chemical Entities (NCEs) and late stage intermediates for the Innovator Companies. Flamma celebrated the Grand Opening of its new state-of-the-art cGMP plant in Dalian, China in June 2025. This milestone aligns with the company’s broader strategy to invest significantly across its global network which included its continued expansion within Italy. Learn more here:

    https://www.flammagroup.com/grand-opening-2025/

  • Brochure FLAMMA Overview

    FLAMMA is a CDMO with Headquarters near Milan, Italy. As a fully integrated CDMO, we can leverage our 100% self-owned, self-managed facilities, in Italy and China to deliver a stable, reliable supply chain. We specialize in the cGMP manufacturing of APIs, NCEs, RSMs, &Advanced intermediates (NCEs and generics). We use our expertise in high value chiral materials (specifically amino acid related materials) to provide solutions to customers who not only have need for chiral materials but also clients who have other requirements with a various type of chemistries. In addition, we also manufacture specialty compounds and advanced intermediates for the nutraceutical and cosmetic industries, and others.
  • Sponsored Content Flamma Group acquires additional API site in Italy

    The company wil acquire a third API manufacturing site in Lecco, Italy as of April this year 

  • Video Flamma: from Yesterday to Today

    Learn about Flamma in under 1 minutes by viewing this video.
  • News Watch now: Pharma Trends 2022 Webinar

    We are approaching the end of a year which saw global vaccine rollout for COVID-19, 44 novel drug approvals (to date) and the return of the CPHI Worldwide in-person event.

  • Brochure The Sting: Scope-changing CDMOs

    This one page article describes the tactics being used in the CDMO industry to gain business that ultimately costs innovator companies more money and time.
  • News Flamma USA opens doors to HPAPI suite

    The CDMO says the suite will help to "bring back manufacturing to the US"
  • Brochure FLAMMA expands its Continuous Flow capabilities in Italy

    Flamma announced the expansion of its Continuous Flow capabilities with the investment of ~$2M
  • News A Word with Flamma

    A short article that features Kenneth Drew, VP Flamma USA discussing what makes Flamma different from other CDMOs.
  • Brochure FLAMMA once again expands its Continuous Flow capabilities in Italy

    FLAMMA announced the another addition to its Continuous Flow capabilities with the addition of a Corning G4 Microreactor.
  • Brochure FLAMMA to invest $200M over the next 3 years

    FLAMMA announced the commitment to invest $200M over the next three years. This significant investment will propel Flamma forward.
  • Report The Flamma Group Expands Globally Reinforcing Its Commitment to Growth

    Chignolo D’Isola, Bergamo, Italy – June 23, 2025 – The Flamma Group  (“Flamma”) is a global, fully integrated company producing and commercializing small molecule Active Pharmaceutical Ingredients (APIs) for the life science industry. As a preeminent Contract Development and Manufacturing Organization (CDMO) of New Chemical Entities (NCEs) and late stage intermediates for the Innovator Companies, Flamma celebrated the Grand Opening of its new state-of-the-art cGMP plant in Dalian, China. This milestone aligns with the company’s broader strategy to invest significantly across its global network which included its continued expansion within Italy.